Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2020

Feb 7, 2020

3358_rpt_2020-02-07_d30cf1aa-50e2-40e3-bef6-e2735916c432.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

7 February 2020

Coloplast A/S Holtedam 1 3050 Humlebæk Denmark Tlf: +45 4911 1111 www.coloplast.com CVR-nr. 69749917

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns sale of shares.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Thomas Barfod
2 Reason for the notification
a) Position/status Member of the Board
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument
B shares
Identification code
ISIN: DK0060448595
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s) Price(s) Volumes(s)
902.60 3,960
Aggregated information
d) -
Aggregated volume
3,960 shares
DKK 902.60
-
Price
e) Date of the transaction 2020-02-06, 13:26 UTC (last trade)
f) Place of the transaction Nasdaq Copenhagen A/S (XCSE)

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: +45 4911 3616.